Monopar Therapeutics - 09 Dec 2024 SCHEDULE 13D/A Report for Gem Pharmaceuticals LLC Common Stock, $0.001 par value (MNPR)

Filing Manager
Monopar Therapeutics
Reporting Manager
Hendricks Diane
Security
Gem Pharmaceuticals LLC Common Stock, $0.001 par value
Symbol
MNPR
Shares outstanding
5,259,918 shares
Disclosed Ownership
704,829 shares
Ownership
13%
Form type
SCHEDULE 13D/A
Filing time
07 Feb 2025, 17:01:45 UTC
Date of event
09 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Monopar Therapeutics 12% 611,079 611,079 0 Karl Leo Managing Member 0001645469
Hendricks Diane 13% 704,829 93,750 611,079 Diane Hendricks Diane Hendricks 0001727478
Leo Karl 13% 642,391 31,312 611,079 Karl Leo Karl Leo 0001727480
Pharma Investments LLC 12% 611,079 0 611,079 Diane Hendricks Managing Member 0001727496